350 related articles for article (PubMed ID: 33955501)
1. Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
Liu Q; Liu DW; Zheng MJ; Deng L; Wang HM; Jin S; Liu JJ; Hao YY; Zhu LC; Lin B
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955501
[TBL] [Abstract][Full Text] [Related]
2. Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells.
Zhuang H; Tan M; Liu J; Hu Z; Liu D; Gao J; Zhu L; Lin B
Mol Cancer; 2014 Nov; 13():243. PubMed ID: 25362534
[TBL] [Abstract][Full Text] [Related]
3. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.
Lee S; Choi S; Lee Y; Chung D; Hong S; Park N
J Obstet Gynaecol Res; 2017 Jan; 43(1):220-227. PubMed ID: 27862665
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
Chen Y; Bieber MM; Teng NN
Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
[TBL] [Abstract][Full Text] [Related]
5. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
6. HDAC3 positively regulates HE4 expression to promote ovarian carcinoma progression.
Lou T; Zhuang H; Liu C; Zhang Z
Arch Biochem Biophys; 2019 Oct; 675():108044. PubMed ID: 31302139
[TBL] [Abstract][Full Text] [Related]
7. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
8. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
Koh I; Hinoi T; Sentani K; Hirata E; Nosaka S; Niitsu H; Miguchi M; Adachi T; Yasui W; Ohdan H; Kudo Y
Cancer Med; 2016 Jul; 5(7):1546-55. PubMed ID: 27060927
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
10. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
[TBL] [Abstract][Full Text] [Related]
12. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
13. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
[TBL] [Abstract][Full Text] [Related]
14. High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Kubota Y; Hamada K; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Kobayashi S; Tsunoda T; Wada S
Int J Oncol; 2021 Jan; 58(1):57-69. PubMed ID: 33367933
[TBL] [Abstract][Full Text] [Related]
15. MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells.
Ren L; Xiao L; Hu J
J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):721-4. PubMed ID: 18231753
[TBL] [Abstract][Full Text] [Related]
16. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.
Zhu L; Guo Q; Jin S; Feng H; Zhuang H; Liu C; Tan M; Liu J; Li X; Lin B
Oncol Rep; 2016 Sep; 36(3):1592-604. PubMed ID: 27430660
[TBL] [Abstract][Full Text] [Related]
18. The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.
James NE; Emerson JB; Borgstadt AD; Beffa L; Oliver MT; Hovanesian V; Urh A; Singh RK; Rowswell-Turner R; DiSilvestro PA; Ou J; Moore RG; Ribeiro JR
Sci Rep; 2020 May; 10(1):8558. PubMed ID: 32444701
[TBL] [Abstract][Full Text] [Related]
19. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
